Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04025853 · ClinicalTrials.gov registry record
Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 455
- Enrollment target
NCT04025853 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 455 participants.
The verdict
NCT04025853 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 455 participants
- Enrollment target
Study Summary
The investigators plan to do a retrospective chart review of 500 patients admitted to the hospital between January 1, 2010 and December 31, 2015 with diabetic foot infections. The investigators will define a positive case of osteomyelitis as bone with positive bacterial cultures or histologic finding of acute or chronic osteomyelitis. Levels of inflammatory biomarkers (CRP, ESR) will be collected from the charts from the first time of diagnosis. Because wound healing, biomarker levels and resolution of infection are clearly affected by other factors such as demographics, medical/surgical history, social history, medications, laboratory results, peripheral arterial disease, wound severity, and treatment factors such as type of antibiotics, off-loading, debridement and vascular surgery interventions these will also be collected. The investigators will collect this clinical data for both cohorts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04025853
The ClinicalTrials.gov registry entry for NCT04025853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04025853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04025853 about?
NCT04025853 is a clinical study titled "Inflammatory Biomarkers to Diagnose and Monitor Diabetic Foot Osteomyelitis". The investigators plan to do a retrospective chart review of 500 patients admitted to the hospital between January 1, 2010 and December 31, 2015 with diabetic foot infections. The investigators will define a positive case of osteomyelitis as bone with positive bacterial cultures or histologic findin...
What is the current status of trial NCT04025853?
This trial is currently completed. The enrollment target is 455 participants. The study started on 2015-06. Estimated completion is 2018-03.
Who is sponsoring clinical trial NCT04025853?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.